Guillain-Barré syndrome and venous thrombosis (9/10)
Researchers observed an increase in cases of Guillain-Barré syndrome and cerebral venous thrombosis after the administration of the first dose of the AstraZeneca vaccine.
Guillain-Barré syndrome is mainly characterized by muscle weakness, while venous thrombosis involves the formation of a blood clot in a vein, obstructing circulation to the rest of the body.
French basketball player Victor Wembanyama suffered from this condition a few months ago, which forced him to end his season.
More research is needed (10/10)
In addition, all vaccines significantly increased the risk of myocarditis and pericarditis— inflammations of the myocardium (the muscle responsible for heart contraction and for circulating blood throughout the body).
“Other issues have been identified that require further research,” notes the journal.
The researchers emphasize that more investigation is needed to determine the relationship between the vaccine and these side effects.
Conclusion
Faced with this alarming situation, COVID-19 vaccines were developed urgently.
After nearly five years of observation and analysis, we now have a better understanding of the side effects of the different vaccines that were administered.
